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ABSTRACT ( 250/250) 
Objective: Erectile dysfunction (ED) may be common among people with diabetes, but its prevalence 
and odds versus controls is still unknown. We therefore aimed to assess the prevalence of ED in 
diabetes via a meta-analysis.   
Research design and methods: We searched major databases from inception to11/2016 for studies 
reporting ED in people with diabetes (type I (T1DM), type II (T2DM) and both). We conducted a 
meta-analysis of the prevalence (and 95% confidence-intervals (CIs)) of ED in diabetes and where 
possible compared this versus healthy controls (HCs), calculating the relative odds ratios (ORs)and 
95% CIs. A random effect model was applied.    
Results:  Out of 3747 initial hits, 145 studies were included representing 88,577 male participants 
with diabetes (55.8±7.9 years, T1DM=5,604, T2DM=44,488, both=20.061, not reported=18,424).  
The overall prevalence of ED in diabetes was 52.5% (95%CI: 48.8-56.2 after adjusting for publication 
bias).  The prevalence of ED was 37.5%, 66.3% and 57.7% in T1DM, T2DM and both respectively (p 
for interaction<0.0001).  The prevalence of ED was highest in studies the Sexual Health Inventory for 
Men (82.2%, studies =17, p for interaction<0.0001). Only higher percentage of people with 
hypertension moderated our results (beta=0.03; 95%CI: 0.008-0.004; p=0.003; R2=0.00). Compared 
to HCs (n=5,385) people with diabetes (n=863) were at increased odds of having ED (OR=3.62; 
95%CI: 2.53-5.16, p<0.0001; I2=67%, k=8).  
Conclusions: ED is common in diabetes, affecting more than half of people with diabetes and is 
approximately 3.5 times more likely versus controls. Our findings screening  and offering appropriate 
interventions for people with ED may be useful.    
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INTRODUCTION 
Diabetes mellitus (DM) is defined as a chronic metabolic disease characterized by hyperglycemia 
resulting from defects in insulin secretion, insulin action or both and leading to hyperglycemia or 
raised blood sugar.(1) The WHO Global Report on Diabetes states that the number of people with 
diabetes has risen from 108 million in 1980 to 422 million in 2014 and that the global prevalence 
among adults has risen from 4.7% to 8.5% in the same years.(2) The main and most considered 
complications of diabetes weigh on the heart, blood vessels, eyes, kidneys, nerves.(3) In addition to 
the traditional complications, diabetes has been associated with increased rates of specific cancers 
(pancreatic, hepatobiliary, breast, endometrial and colorectal cancer)(4) and physical and cognitive 
disability, and finally to depression.(5; 6)  
 
Increasing attention is turning to erectile dysfunction (ED) in diabetic patients due to its multifactorial 
pathophysiology and the concurrence of the same components as vasculopathy, neuropathy and 
depression. (7) ED is defined as the inability to achieve and/or maintain an erection sufficient to permit 
satisfactory sexual intercourse.(7) Although ED is considered an age-related disease affecting 20% of 
men above 40 years, also before it can be present especially when coexist risk factors as diabetes, 
metabolic syndrome or cardiovascular diseases, although it is probably underestimated in younger 
people.(8) DM is considered the main risk factor for the development of ED and since the 70s the 
association between DM and the development of erectile dysfunction has been documented both in 
animal models and humans.(9; 10)  
 
Although previous studies have suggested that ED is more prevalent in people with diabetes compared 
to  healthy subjects(11), the exact prevalence of this condition is still unclear in people with DM.  A 
number of narrative reviews(12-15) have considered the prevalence of ED in DM and the majority 
agree that the incidence of ED in men with diabetes is two/three-fold higher than in the general 
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population. It is estimated that ED affects up to 75% of all diabetic men, it is age correlated and occurs 
at a younger age in patients with DM. 
Even if all these works advanced our knowledge regarding this issue, the exact prevalence of ED in DM 
is still not known, but it could be of importance since ED, for example, is associated with higher 
cardiovascular risk in people with DM. (16-20).  Moreover, no meta-analysis has compared the odds 
of ED versus controls and meta-regression of the factors which may influence ED among people with 
diabetes are not known.   
  
Given this background, the aim of this study was to assess the prevalence of ED in diabetes, using a 
meta-analytic approach.   
5 
 
METHODS 
This systematic review adhered to the PRISMA(21) and MOOSE(22) statements and followed an a 
priori defined, but unpublished protocol. 
 
Data sources and literature search strategy 
Two investigators (DP and YK) independently conducted a literature search using PubMed, EMBASE, 
SCOPUS, from database inception until 01st November, 2016.  All the studies reporting the prevalence 
of ED in diabetes were considered. In PubMed, the following search strategy was (diabetes*) AND 
(erectile dysfunction OR erectile function OR sexual dysfunction OR sexual function) AND (prevalence 
or odds or risk). An identical search was conducted in the other databases.  Conference abstracts and 
reference lists of included articles were hand-searched to identify and potential additional relevant 
articles. Any inconsistencies were resolved by consensus with a third author (BS). 
 
Study selection  
Studies were included in meta-analysis if: i) reported the prevalence of ED; ii) used a validated 
instrument for the diagnosis of ED such as the international index of erectile function (IIEF)(23) or the 
Sexual Health Inventory for Men (24)(SHIM); iii) included people with a validated diagnosis of diabetes 
(e.g. with the criteria suggested by the American Diabetes Association)(1) ; iv) included male 
participants.  
Studies were excluded if: i) were not conducted in humans; ii) included participants with ED, but not 
diabetes; iii) included participants having all both diabetes and ED (i.e. prevalence=100% and a biased 
sample); iv) included only females.  
 
 
 
Data extraction  
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Two independent investigators (DP and YK) extracted key data from the included articles in a 
standardized Excel sheet and a third independent investigator (NV) validated data extraction. For each 
article, we extracted data regarding authors, year of publication, country, setting, demographics (i.e. 
sample size, mean age), type of diabetes, diagnostic criteria used for ED, duration of diabetes, 
percentage of participants having the most common complications of diabetes (neuropathy, 
retinopathy, cardiovascular disease, kidney failure) and some known risk factors for ED (smoking, 
obesity, hypertension).  
When some information was missing, first and/or corresponding authors of the original article were 
contacted at least two times in a month to obtain the variables of interest. For 23 eligible papers, we 
were unable to acquire the full texts and the authors did not respond to our requests.  However, these 
conference abstracts contained sufficient data for meta-analysis.   
 
Outcomes 
The main outcome of interest was the prevalence of ED in people with diabetes reported in the original 
paper both as percentage or as number of ED/number of people with diabetes. Where available, also 
data regarding the prevalence of ED in healthy controls with no diabetes was extracted.  
 
Assessment of study quality 
Two authors (NV, DP) assessed the quality of the studies included taking in account these factors: i) 
clear diagnostic criteria for diabetes; ii) clear diagnostic criteria for ED; iii) reporting the prevalence of 
at least one diabetic complication; iv) reporting data on the duration of diabetes.  
 
 
 
Data synthesis and statistical analysis  
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All analyses were performed using Comprehensive Meta-Analysis (CMA) 3 (http://www.meta-
analysis.com).  
 
In the primary analysis, we calculated the prevalence of ED in diabetes with its 95% confidence 
intervals (CIs) applying a random-effect model due to an anticipated heterogeneity.(25) The 
prevalence was reported as percentage. In secondary analysis, the prevalence of ED in diabetic vs. 
controls was compared using odds ratios (ORs) with their 95%Cis.  
 
Heterogeneity across studies was assessed by the I2 metric and Cochran’s Q chi-square statistics with 
a value>50% for the first and a p-value<0.05 indicating the presence of a significant heterogeneity.(26) 
In case of high heterogeneity, sensitivity and meta-regression analyses were run in order to identify 
possible moderators of this heterogeneity. In sensitivity analyses, we stratified our results by 
continent (Africa, Asia, Europe, North and South America, Oceania, multi-continent), type of diabetes 
(type 1, 2, studies including both forms, or not declared), setting (community, outpatients, not 
declared), type of article (original article or conference abstract), diagnostic tools for the presence of 
ED (IIEF-5, SHIM or other tools) and mean age (divided in 18-60 years and > 60 years or not declared). 
In meta-regression analysis, we analyzed some potential moderators as continuous variables in the 
sample as whole, namely: duration of diabetes (years), percentage of people with neuropathy, 
retinopathy, cardiovascular disease, kidney failure, hypertension; mean body mass index; percentage 
of actual smokers. 
 
Publication bias was assessed by visually inspecting funnel plots and using the Egger bias test.(27) 
Then, to account for publication bias, we used the trim-and-fill method, based on the assumption 
that the effect sizes of all the studies are normally distributed around the center of a funnel plot; in 
the event of asymmetries, it adjusts for the potential effect of unpublished (imputed) studies.(28) 
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Finally, we calculated the fail-safe number of negative studies that would be required to nullify each 
of our comparative analyses (i.e., result in p>0.05). 
 
For all analyses, p<.05 was considered statistically significant. 
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RESULTS 
 
Search results 
The search yielded 3,747 non-duplicated articles. After excluding 3,441 articles based on title/abstract 
review, 306 articles were retrieved for full text review and 145 studies were finally included (Figure 
1).  
 
Study and participants’ characteristics  
Full descriptive details of the included studies are reported in Supplementary Table 1.  
 
Altogether, this meta-analysis included 145 studies (for the references see Supplementary Table 2) 
and 88,577 male participants with diabetes aged a mean of 55.8±7.9 years (range:23.4-71.7 years). 
The majority of the studies was made in Asia (61 studies, =41.8%), followed by Europe (48, =32.9%), 
North America (17, =11.6%) and Africa (15, =10.3%). All studies, except 14, were made among 
outpatients. Finally, most studies included people having a diagnosis of type 2 diabetes (70 studies for 
a total of 44,488 participants), followed by studies that did not declare which type of diabetes was 
included (45 studies, n=18,424), both type 1 and 2 (18 studies, n=20,061) and only type 1 (12 studies, 
n=5,604). The presence of ED was diagnosed mainly through the IIEF-5 (n=90 studies).  
The most common source of bias was the absence of data regarding diabetic complications, since 
these information were present in only 32 (=22.1%) of the studies included.  
 
Prevalence of ED in diabetes 
As shown in Table 1, the overall prevalence of ED in diabetes was 59.1% (95%CI: 55.5-62.7). This 
finding was characterized by a high heterogeneity (I2=99%) and by a publication bias (Egger’s 
test=3.71±1.32, p=0.006). After conducting the trim and fill analysis, 20 studies missing on the  left 
were adjusted and the adjusted prevalence of ED in diabetes was 52.5% (95%CI: 48.8-56.2) (Table 1).  
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Factors affecting ED prevalence 
As shown in Table 1, the prevalence of ED was significantly higher (between groups p-value<0.0001) 
in the studies made in South America (prevalence=74.6%; 1 study), Oceania (prevalence=74.4%; 1 
study) and Africa (prevalence=71.3%; 15 studies) and lower among North Americans 
(prevalence=34.5%; 17 studies).  
The prevalence of ED resulted significantly higher in patients with type 2 diabetes (prevalence=66.3%; 
70 studies) compared to type 1 diabetes (prevalence=37.5%; 12 studies) (p for interaction<0.0001). 
Moreover, the prevalence of ED was significant higher in the studies using the SHIM for assessing ED 
(prevalence=82.2%; 17 studies) and those having a mean age over 60 years (prevalence=66.7%; 23 
studies) (Table 1).  On the contrary, the setting in which the study was performed (p for 
interaction=0.37) and the type of article (p for interaction=0.79) resulted no significant moderators of 
our findings.  
 
Meta-regression analysis 
Since our main outcome was characterized by a high heterogeneity (I2=99%) and the stratification 
shown in Table 1 was not able to explain any heterogeneity, we assessed if other factors could explain 
this heterogeneity. As shown in Table 2 among some potential possible moderators (including the 
most common chronic complication of diabetes, duration of diabetes and risk factors for ED such as 
smoking) only higher percentage of people with hypertension moderated our results (beta=0.03; 
95%CI: 0.008-0.004; p=0.003) without, however, explaining any heterogeneity (R2=0.00).  
 
Comparison with the controls 
Eight studies (29-36) reported the prevalence of ED in diabetic (n=863) versus healthy controls 
(n=5,385). As shown in Figure 2, the prevalence of ED in diabetic people vs. controls was almost 
doubled (51.6% vs. 25.5%), leading to an overall OR=3.62 (95%CI: 2.53-5.16, p<0.0001; I2=67%). No 
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evidence of publication bias was present for this outcome (Egger’s test=2.21±1.44, p=0.17) and the 
fail-safe number was 311. 
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DISCUSSION 
To the best of our knowledge, this is the first meta-analysis to assess the prevalence of ED in diabetes 
mellitus synthesizing a large volume of international literature (including 145 studies and 88,577 male 
diabetic participants). We showed an overall prevalence of ED of 59.1% in diabetes patients (52.5% if 
adjusted for publication bias). This condition was significantly higher in people with type 2 diabetes 
compared to type 1 diabetes, and in older participants.   Men with diabetes tend to develop erectile 
dysfunction 10 to 15 years earlier than men without diabetes.(37) In fact, ED is the third most frequent 
complication of diabetes that affects the quality of life and it is often indicative of underlying 
vasculopathy representing a predictor of more serious cardiovascular disorders.(38) As the prevalence 
of diabetes rises inexorably in high, middle, and low income countries alike, our work aimed to give 
an overall estimate of ED in diabetes.  
 
One of our main results is that the prevalence of ED in diabetes patients is 3 folds higher than controls 
with an overall OR=3.62 (95%CI: 2.53-5.16, p<0.0001; I2=67%) and more higher among patients with 
a mean age over 60 years. These findings are consistent with the Massachusetts Male Aging Study(39) 
in which diabetic men showed a threefold probability of having ED than men without diabetes and 
the age-adjusted risk of ED was doubled in diabetic men compared with those without diabetes.(40) 
Notably, the global ageing of the world population as well as the dramatical increasing prevalence of 
diabetes mellitus may explain the worldwide prevalence of ED, which has been estimated to 322 
million cases by the year 2025.(41) 
 
A comprehensive review including high-quality studies undertaken by Kamenov and colleagues(14) 
agreed with our findings that advanced age and type 2 diabetes are associated with an increased risk 
of ED. In addition, as shown in our analyses the prevalence of ED in type 2 diabetes patients is higher 
compared to type 1 diabetes.  Indeed, many patients may already have ED at the diagnosis of type 2 
diabetes. ED has been proven to be the first sign of diabetes, diagnosed later in 12–30 % of men.(42) 
13 
 
Recently, Corona et al., found in a sample of 499 men (mean age 58.8 ± 8.8 years) with new or recently 
diagnosed type 2 diabetes mellitus: mild ED in 19.4 %, mild-to-moderate in 15.4 %, moderate in 10.4 
%, and severe in 21.6 % of patients. (43) 
 
Several cross-sectional and longitudinal studies showed an association between ED and most of the 
classical cardiovascular risk factors, including smoking(44), diabetes(45), hypertension(46), 
hyperlipidemia(47), metabolic syndrome(48), as well as depression.(49) Surprisingly, in our meta-
regression analysis, hypertension only was associated with the diabetes-related ED (p=0.003). 
However, in a large survey of 7689 patients with diabetes and/or hypertension, ED according to the 
IIEF-5 score was present in 67% of patients with hypertension alone, in 71% with diabetes alone, and 
increased to 77% of patients with both diseases.(46) 
 
There is increasing evidence of a direct link between ED and cardiovascular diseases.(50) ED is a 
marker of early atherosclerosis and it is considered not only as a part of the quality of life but also as 
an independent predictor of cardiovascular events and all-cause mortality as well.(51) Several 
identified factors contribute to the complex pathogenesis of diabetes related ED including diabetic 
neuropathy, micro- and macro-vascular arterial disease (oxidative stress, endothelial dysfunction, 
dyslipidemia, arterial hypertension, etc.), hypogonadism, psychogenic components and drug side 
effects.(14; 52) The diagnostic process is based on the results of standardized questionnaires, vascular 
and neurological investigations. One of the most used and practical questionnaires that is 
administered is the International Index of Erectile Function (IIEF)-5, whom a score of 21 or less 
indicates the presence of ED.(53) However, depending on the age, duration and type of diabetes 
mellitus and the used diagnostic criteria epidemiological data about diabetes related ED vary 
significantly between different studies.(38) Our analysis show large differences in the reported 
prevalence of ED approximately from 35% to 80% among diabetic men which could be due to 
differences in methodology and population characteristics. Advancing age, duration of diabetes, poor 
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glycaemic control, hypertension, hyperlipidemia, sedentary lifestyle, smoking, and presence of other 
diabetic complications have been shown to be associated with diabetes related ED in cross-sectional 
studies.(38)  
ED  
Regarding sexual activity and the psychological impact of ED in patients with diabetes mellitus, 
significant and positive associations between depressive symptoms and ED have been found. In 
addition, ED strongly contributes to poorer quality of life in patients with diabetes mellitus. Therefore, 
early detection of ED is essential to improve the psychological health and patients' quality of life.  
Whilst our data offers novel insight into the extent of ED among people with diabetes, some 
limitations need to be considered. One of them is the difficulty to provide the ED prevalence by 
categories because of incomplete data available in published studies. Secondly, most information 
refers to the total diabetic population and few studies have presented data separately for Type 1 and 
Type 2 diabetes patients. And thirdly, the analysis of the others risk factors contributing to the 
diabetes-related ED was limited because of the small number of primary studies that provide complete 
clinical and biological features of the patients.  
 
In conclusion, our study provides worldwide data on the prevalence of and risks factors for ED in 
diabetes. The relationship of ED with certain risk factors, such as age or cardiovascular risk factors 
(arterial hypertension), are well known and our study corroborates these associations. Future 
prospective and longitudinal studies in both but separately type 1 and type 2 diabetes population, are 
needed to characterize others risk factors such as duration of disease or smoking which are involving 
in the development of ED. Furthermore, patients with erectile dysfunction are at an increased risk for 
cardiovascular morbidity and/or mortality as well as for all-cause death. Thus, clinicians should have 
in mind that screening of ED in diabetes patients is a part of the assessment of their cardiovascular 
risk. 
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Table 1-Meta-analysis results of prevalence of erectile dysfunction in people with diabetes  
 
Outcome 
Number of 
study 
estimates 
Number of 
participants 
Prevalence 
(%) 
95% CI Between group p value 
I2 
(%) 
ED (main analysis) 145 88,577 59.1 55.5 62.7 - 99 
Continent      <0.0001  
Africa 15 2,055 71.3 63.2 78.2  92 
Asia 61 36,032 67.0 60.4 73.1  99 
Europe 48 3,7300 53.6 48.7 58.3  99 
North America 17 10,509 34.5 26.1 44.0  99 
South America 1 114 74.6 65.8 81.7  - 
Oceania 1 788 74.4 71.2 77.3  - 
Multi-continent 2 1,779 39.7 37.5 42.0  0 
Type of diabetes      <0.0001  
Type 1 12 5,604 37.5 30.8 44.6  96 
Type 2 70 44,488 66.3 61.5 70.9  99 
Both  18 20,061 57.7 47.6 67.2  99 
Not declared 45 18,424 53.9 45.6 62.0  99 
Setting      0.37  
Community 9 3,163 66.9 52.5 78.7  98 
Outpatients 131 84,225 58.8 54.9 62.7  99 
Not declared 5 1,189 52.8 39.0 66.2  94 
Type of article      0.79  
Original article 114 72,371 59.4 55.2 63.5  99 
Conference abstract 31 16,206 58.2 50.2 65.8  99 
Diagnosis of ED      <0.0001  
IIEF-5 90 41,025 60.7 55.9 65.3  99 
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Abbreviations:  
  
SHIM 17 7,093 82.2 74.8 87.7  99 
Other 38 40,459 42.3 37.1 47.7  99 
Mean age      0.03  
18-60 years 55 21,220 62.2 56.1 67.9  99 
>60 years 23 10,432 66.7 57.5 74.8  99 
Not declared 67 56,925 53.8 48.3 59.3  99 
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Table 2. Meta regression of continuous moderators of erectile dysfunction presence in people with diabetes. 
Moderator* 
Number of 
comparisons 
β 95% CI P-value R² 
Duration of diabetes (years) 46 -0.02 -0.05 0.00 0.08 0.06 
Percentage of people with neuropathy  32 0.02 -0.00 0.04 0.08 0.00 
Percentage of people with retinopathy  30 0.004 -0.01 0.02 0.66 0.00 
Percentage of people with cardiovascular disease  38 -0.005 -0.03 0.01 0.56 0.00 
Percentage of people with kidney failure  22 0.02 -0.005 0.05 0.11 0.05 
Mean body mass index 31 0.06 -0.06 0.18 0.30 0.00 
Percentage of actual smokers  49 -0.007 -0.03 0.007 0.33 0.00 
Percentage of people with hypertension  50 0.03 0.008 0.04 0.003 0.00 
 
Abbreviations: 
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Figure 1. PRISMA flow-chart 
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Figure 2. Prevalence of erectile dysfunction in diabetic and control subjects.  
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Supplementary Table 1. Descriptive characteristics of the studies included.  
Author, year Number of participants Country Type of diabetes Setting Diagnosis ED 
Ab Rahman AA et al., 2011 544 Malaysia Not available Outpatients IIEF-5 
Adebusoye LA et al., 2012 33 Nigeria Not available Outpatients IIEF-5 
Adegite A et al., 2009 66 Nigeria Type 2 Outpatients IIEF-5 
Ahmad S et al., 2010 281 Malaysia Not available Outpatients IIEF-5 
Ahmed A et al., 2011 
333 Quatar Not available Outpatients SHIM 
Ahmed I et al., 2013 217 Pakistan Type 2 Outpatients SHIM 
Ahn TY et al., 2007 127 Korea Not available Community IIEF-5 
Al Naimi A et al., 2014 209 Quatar Not available Outpatients IIEF-5 
Al-Hunayan A et al., 2007 323 Kuwait  Type 2 Outpatients IIEF-5 
AlMogbel TA., 2014 376 Saudi Arabia Type 2 Outpatients IIEF-5 
Al-Turki YA., 2007 186 Saudi Arabia Both Outpatients Other 
Ashok Shenoy K et al., 2012 50 India Type 2 Outpatients Other 
Awad H et al., 2010 100 Egypt  Type 2 Outpatients IIEF-5 
Bacon CG et al., 2002 2108 USA Both Outpatients Other 
Batty GD et al., 2010 6304 United Kingdom Type 2 Outpatients Other 
Berrada S et al., 2003 34 Marocco  Not available Community Other 
Bjerggaard M et al., 2015 481 Denmark Not available Outpatients IIEF-5 
Blans MCA 90 Netherlands  Both Outpatients IIEF-5 
Blumentals WA et al., 2003 3160 United Kingdom Not available Outpatients Other 
Boyd MJ et al., 2009 180 United Kingdom Type 2 Outpatients Other 
Brooke JC et al., 2011 356 United Kingdom Not available Not available IIEF-5 
Cander S et al., 2014 68 Turkey Type 2 Outpatients IIEF-5 
Caretta N et al., 2016 92 Italy Type 2 Outpatients IIEF-5 
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Author, year Number of participants Country Type of diabetes Setting Diagnosis ED 
Cavan DA et al., 1987 292 Scotland Not available Outpatients Other 
Chakraborty K et al., 2013 84 India Not available Outpatients IIEF-5 
Chaudhary RK et al., 2016 175 China Type 2 Outpatients IIEF-5 
Chew SK et al., 2013 324 Singapore Type 2 Outpatients Other 
Chew SKH et al., 2013 289 Singapore Type 2 Outpatients Other 
Cho NH et al., 2006 1312 Korea Type 2 Outpatients IIEF-5 
Chuang YC et al. 2012 455 China Type 2 Outpatients SHIM 
Cleveringa FGW et al., 2009 1611 Netherlands  Type 2 Outpatients Other 
Corona G et al., 2014 1503 Italy Type 2 Outpatients IIEF-5 
Dan A et al., 2014 113 India Both Outpatients IIEF-5 
De Berardis G et al., 2003 1460 Italy Type 2 Outpatients Other 
De Berardis G et al., 2007 670 Italy Type 2 Outpatients Other 
Derosa G et al., 2012 88 Italy Type 2 Outpatients IIEF-5 
Derosa G et al., 2015 206 Italy Type 2 Outpatients IIEF-5 
Eardley I et al., 2007 1556 Multicountry  Not available Community Other 
El Saghier EOA et al., 2015 70 Egypt  Type 2 Outpatients IIEF-5 
Elbendary MA et al., 2009 38 Egypt  Not available Outpatients IIEF-5 
Fedele D et al., 2000 9756 Italy Both Outpatients Other 
Feldman HA et al., 1994 120 USA Not available Outpatients IIEF-5 
Fukui M et al., 2011 197 Japan Type 2 Outpatients IIEF-5 
Furukawa S et al. 2016 332 Japan Type 2 Outpatients SHIM 
Furukawa S et al., 2016 340 Japan Type 2 Outpatients SHIM 
Garcia-Malpartida K et al., 2011 154 Spain Type 2 Outpatients IIEF-5 
Gazzaruso C et al., 2004 260 Italy Type 2 Outpatients IIEF-5 
Gazzaruso C et al., 2011 293 Italy Type 2 Outpatients IIEF-5 
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Author, year Number of participants Country Type of diabetes Setting Diagnosis ED 
Georgescu O et al., 2010 292 Romania Not available Outpatients IIEF-5 
Georgescu O et al., 2013 292 Romania Both Outpatients IIEF-5 
Ghalayini IF et al., 2010 118 Jordan Not available Community IIEF-5 
Ghazi S et al., 2012 391 Egypt  Type 2 Outpatients IIEF-5 
Ghenciu V et al., 2012 45 Moldavia Type 2 Not available Other 
Giorda CB et al., 2013 1503 Italy Type 2 Outpatients Other 
Giugliano F et al., 2010 555 Italy Type 2 Outpatients IIEF-5 
Giuliano FA et al., 2004 2377 France Both Outpatients IIEF-5 
Goyal A et al., 2013 348 India Not available Outpatients IIEF-5 
Habibi A et al., 2011 171 Iram Type 2 Outpatients IIEF-5 
Habibi A, 2010 171 Iram Not available Outpatients IIEF-5 
Hackett G et al., 2013 190 United Kingdom Type 2 Outpatients IIEF-5 
Hackett GI et al., 2009 415 United Kingdom Type 2 Outpatients SHIM 
Hamilton EJ et al., 2016 788 Australia Type 2 Community SHIM 
Hassan A et al., 2014 429 Saudi Arabia Type 2 Outpatients ADAM 
Henis O et al., 2011 102 Israel Type 2 Outpatients SHIM 
Hermans MP et al., 2009 221 Belgium Type 2 Outpatients IIEF-5 
Hopcan MB et al., 2010 372 Turkey Not available Outpatients IIEF-5 
Hotaling J et al., 2010 528 USA Not available Outpatients IIEF-5 
Hotaling JM et al., 2012 528 USA Type 1 Outpatients IIEF-5 
Idung AU et al., 2012 86 Nigeria Not available Outpatients IIEF-5 
Jacobson AM et al., 2013 664 USA Type 1 Outpatients IIEF-5 
Jacobson AM et al., 2015 644 USA Type 1 Outpatients IIEF-5 
Jamieson F et al., 2008 142 United Kingdom Type 1 Outpatients Other 
Jayanthy R et al., 2014 60 India Not available Not available IIEF-5 
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Author, year Number of participants Country Type of diabetes Setting Diagnosis ED 
Jayawardena RM et al., 2013 536 Sri Lanka Not available Outpatients IIEF-5 
Jiann BP et al., 2009 844 Taiwan Type 2 Outpatients SHIM 
Justo D et al., 2010 103 Israel Not available Outpatients SHIM 
Kalter-Leibovici O et al., 2005 1040 Israel Both Outpatients IIEF-5 
Kamenov ZA et al., 2007 150 Bulgaria Both Outpatients Other 
Kapoor D et al., 2007 198 United Kingdom Type 2 Outpatients ADAM 
Katulanda P et al., 2014 125 Sri Lanka Not available Outpatients Other 
Kempa T et al., 2015 150 South Africa Both Community SHIM 
Khatib FA et al., 2006 988 Jordan Not available Outpatients IIEF-5 
Klein R et al., 1996 359 USA Not available Outpatients Other 
La Vignera S et al., 2009 110 Italy Not available Outpatients IIEF-5 
Liu HY et al. 2016  785 China Type 2 Outpatients SHIM 
Liu RT et al., 2012 453 China Type 2 Outpatients SHIM 
Lo WH et al., 2014 603 China Type 2 Outpatients IIEF-5 
Lu CC et al., 2009 792 Taiwan Type 2 Outpatients SHIM 
Ma RCW et al., 2008 2306 China Type 2 Outpatients Other 
Maiorino MI et al., 2015 118 Italy Type 1 Outpatients IIEF-5 
Maiorino MI et al., 2016 151 Italy Type 1 Outpatients IIEF-5 
Majzoub A et al., 2015 1052 Quatar Not available Outpatients IIEF-5 
Malavige LS et al., 2008 253 Sri Lanka Type 2 Outpatients IIEF-5 
Malavige LS et al., 2015 232 United Kingdom Not available Outpatients IIEF-5 
Malavige LS., 2010 232 United Kingdom Not available Outpatients IIEF-5 
Mansour A.A. 2414 Iraq Type 2 Outpatients Other 
McCulloch DK et al., 1980 541 Germany Not available Outpatients Other 
Meena BL et al., 2009 50 India Type 2 Outpatients IIEF-5 
32 
 
Author, year Number of participants Country Type of diabetes Setting Diagnosis ED 
Mehtiyev TV, 2015 261 Azerbaijan Type 2 Outpatients IIEF-5 
Meo SA et al., 2011 2250 Saudi Arabia Not available Outpatients IIEF-5 
Miccoli R et al., 1985 77 Italy Not available Outpatients Other 
Miccoli R et al., 1987 128 USA Not available Outpatients Other 
Mofid A et al., 2009 700 Iran Both Outpatients Other 
Mota M et al., 2003 310 Romania Not available Outpatients SHIM 
Mutagaywa RK et al., 2014 312 Tanzania Both Outpatients IIEF-5 
Nakanishi S et al., 2004 112 Japan Type 2 Outpatients Other 
Nam SM et al., 2010 300 Korea Type 2 Outpatients IIEF-5 
Nasser J et al., 2015 415 Bahrain Type 2 Outpatients IIEF-5 
Nicolosi A et al., 2003 223 Multicountry  Not available Community Other 
Olarinoye JK et al., 2006 77 Nigeria Type 2 Outpatients IIEF-5 
Owiredu WKBA et al., 2011 274 Ghana Not available Outpatients GRISS 
Penson DF et al., 2009 571 USA Type 1 Outpatients IIEF-5 
Pop-Busui R et al., 2013 644 USA Type 1 Outpatients IIEF-5 
Pop-Busui R et al., 2014 635 USA Type 1 Not available IIEF-5 
Pop-Busui R et al., 2015 635 USA Type 1 Outpatients IIEF-5 
Rombopoulos G et al., 2009 400 Greece Not available Outpatients IIEF-5 
Rosen RC et al., 2009 373 USA Type 2 Outpatients IIEF-5 
Rozhivanov RV et al., 2006 611 Bulgaria Both Outpatients Other 
Rutte A et al., 2015 108 Netherlands  Type 2 Outpatients IIEF-5 
Rutte A et al., 2015 154 Netherlands  Type 2 Outpatients BSSC-M 
Sampanis C et al., 2012 93 Greece Type 2 Not available IIEF-5 
Schaan BD et al., 2013 114 Brazil Type 2 Outpatients IIEF-5 
Selim S et al., 2015 3790 Bangladesh Type 2 Outpatients IIEF-5 
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Author, year Number of participants Country Type of diabetes Setting Diagnosis ED 
Seyam RM et al., 2003 40 Egypt  Not available Community Other 
Seyoum B., 1998 292 Ethiopia  Both Outpatients Other 
Shabsigh R et al., 2010 234 USA Not available Outpatients IIEF-5 
Shankar A et al., 2013 582 India Type 2 Outpatients SHIM 
Shi MD et al., 2014 105 Taiwan Type 2 Outpatients IIEF-5 
Song HJ et al., 2013 124 Korea Type 2 Outpatients IIEF-5 
Sonomtseren S et al., 2009 146 Mongolia Type 2 Outpatients IIEF-5 
Taloyan M et al., 2012 190 Sweden Type 2 Outpatients Other 
Tisdall AR et al., 2009 70 Ireland Not available Outpatients IIEF-5 
Turek SJ et al., 2013 301 USA Type 1 Outpatients IIEF-5 
Vaswani A.S et al., 2011 390 Pakistan Not available Outpatients IIEF-5 
Viswanathan V et al., 2009 423 India Type 2 Outpatients IIEF-5 
Wang CC et al., 2010 226 Taiwan Type 2 Outpatients IIEF-5 
Wang F et al., 2013 1466 Canada Both Outpatients Other 
Webb EM et al., 2015 92 South Africa Both Outpatients SHIM 
Wessells H et al., 2011 571 USA Type 1 Outpatients IIEF-5 
Wu C et al., 2012 127 China Not available Community IIEF-5 
Yamasaki H et al., 2004 82 Japan Type 2 Outpatients IIEF-5 
Yang G et al., 2010 5477 China Type 2 Outpatients IIEF-5 
Yildiz H et al., 2015 127 Turkey Both Outpatients IIEF-5 
Yu LW et al., 2010 313 China Type 2 Outpatients IIEF-5 
Ziaei-Rad M et al., 2010 199 Iran Both Outpatients IIEF-5 
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Author, year Number of participants Country Type of diabetes Setting Diagnosis ED 
Total  88,577   
Type 1: 12; type 2: 
70; both: 18; not 
declared: 45 
Outpatients: 
131; 
community: 9; 
not declared: 
5 
IIEF-5: 90; SHIM: 17; 
others: 38 
 
Abbreviations: 
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Supplementary Table 2. References of the studies included in the meta-analysis.  
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